|
FOR IMMEDIATE RELEASE
August 29, 2023 PIPC has released a statement on the list of drugs that will be subject to Medicare price negotiation under the Inflation Reduction Act. |
PIPC Statement on Selection of Drugs under Medicare Drug Price Negotiation Program Guidance8/29/2023
In this week's edition...
— PIPC Submits Comments on ICER Assessment of MLD Treatments. Click here to read the letter. — PIPC Submits Comments on CMS Proposed Guidance for Coverage with Evidence Development. Click here to read the article. — Takeaways from AcademyHealth’s Organizational Briefing with PCORI Executive Director Nakela Cook. Click here to read the blog. — ICHOM Seeks Input on Patient Charter. See details below. — Emerging Threats in States for Use of Discriminatory Metrics. See details below. — What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below. — ICER's QALY-Based Study Topics. See details below. — Upcoming Events and Webinars. See details below. — AHRQ Effective Program Updates. See details below. — Job Openings. See details below. In this week's edition...
— PIPC Submits Comments on CMS Proposed Guidance for Coverage with Evidence Development. Click here to read the article. — ICHOM Seeks Input on Patient Charter. See details below. — New ASPE Report Assesses Relevant Outcomes for Patient-Centered Outcomes Research. See details below. — Patient Engagement Is Key to the Success of Value-Based Care Programs. Click here to read the column. — AAPD: What Health Equity Means to the Disability Community. Click here to read the blog. — Drugs Extending My Life, but Boston Institute Disagrees. Click here to read the op-ed. — Emerging Threats in States for Use of Discriminatory Metrics. See details below. — What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below. — ICER's QALY-Based Study Topics. See details below. — Upcoming Events and Webinars. See details below. — AHRQ Effective Program Updates. See details below. — Job Openings. See details below. In this week's edition...
— Drugs Extending My Life, but Boston Institute Disagrees. Click here to read the op-ed. — How CMS Can Advance – or Impede – Patient-Centered Decision-Making in its New Drug Pricing Program. Click here to read the column, — QALYs: The Math Doesn’t Work. Click here to read the article. — Opinion: Drug Pricing and the 'Impossible Trinity' for Patients. Click here to read the op-ed. — PIPC Collaborates with Avalere on Investigation of Use of Patient-Centered Outcomes in Value Assessment. See details below. — CCD Pens Letter of Support for Protecting Healthcare for All Patients Act. Click here to read the letter. — Chairman's Corner: I introduced the ADA 35 years ago. Now Congress needs to act to ban a practice that devalues disabled lives. Click here to read the op-ed. — Emerging Threats in States for Use of Discriminatory Metrics. See details below. — What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below. — ICER's QALY-Based Study Topics. See details below. — Upcoming Events and Webinars. See details below. — AHRQ Effective Program Updates. See details below. |
Topics
All
Archives
June 2025
|
